Free Trial

HTG Molecular Diagnostics (HTGMQ) Short Interest Ratio & Short Volume

HTG Molecular Diagnostics Short Interest Data

HTG Molecular Diagnostics (HTGMQ) has a short interest of 1,500 shares, representing 0.07% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 15.0, indicating that it would take 15.0 days of the average trading volume of 2,292 shares to cover all short positions.

Current Short Interest
1,500 shares
Previous Short Interest
1,500 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$0.00
Short Interest Ratio
15.0 Days to Cover
Last Record Date
May 31, 2025
Outstanding Shares
2,210,000 shares
Short Percent of Float
0.07%
Today's Trading Volume
0 shares
Average Trading Volume
2,292 shares
Today's Volume Vs. Average
0%
Short Selling HTG Molecular Diagnostics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for HTG Molecular Diagnostics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HTGMQ Short Interest Over Time

HTGMQ Days to Cover Over Time

HTGMQ Percentage of Float Shorted Over Time

HTG Molecular Diagnostics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/20251,500 shares $0.00 No Change0.1%15 $0.00
5/15/20251,500 shares $0.00 No ChangeN/A0 $0.00
4/30/20251,500 shares $0.00 No ChangeN/A0 $0.00
4/15/20251,500 shares $0.00 No ChangeN/A15 $0.00
3/14/20251,500 shares $0.15 No ChangeN/A0.8 $0.00
2/14/20251,500 shares $0.00 No ChangeN/A0 $0.00
1/31/20251,500 shares $0.00 No ChangeN/A0 $0.00
1/15/20251,500 shares $0.00 No ChangeN/A3.8 $0.00

HTGMQ Short Interest - Frequently Asked Questions

What is HTG Molecular Diagnostics' current short interest?

Short interest is the volume of HTG Molecular Diagnostics shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 1,500 shares of HTGMQ short. 0.07% of HTG Molecular Diagnostics' shares are currently sold short. Learn More on HTG Molecular Diagnostics' current short interest.

What is a good short interest ratio for HTG Molecular Diagnostics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HTGMQ shares currently have a short interest ratio of 15.0. Learn More on HTG Molecular Diagnostics's short interest ratio.

What is a good short interest percentage for HTG Molecular Diagnostics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of HTG Molecular Diagnostics' floating shares are currently sold short.

How does HTG Molecular Diagnostics' short interest compare to its competitors?

0.07% of HTG Molecular Diagnostics' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to HTG Molecular Diagnostics: Trane Technologies plc (1.39%), Keysight Technologies Inc. (1.31%), Veralto Corporation (1.17%), Fortive Corporation (1.97%), Teradyne, Inc. (3.97%), Revvity Inc. (4.96%), Avantor, Inc. (5.17%), Nova Ltd. (5.56%), Vontier Corporation (1.79%), Mirion Technologies, Inc. (5.42%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short HTG Molecular Diagnostics stock?

Short selling HTGMQ is an investing strategy that aims to generate trading profit from HTG Molecular Diagnostics as its price is falling. HTGMQ shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against HTG Molecular Diagnostics?

A short squeeze for HTG Molecular Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HTGMQ, which in turn drives the price of the stock up even further.

How often is HTG Molecular Diagnostics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HTGMQ, twice per month. The most recent reporting period available is May, 31 2025.




This page (NASDAQ:HTGMQ) was last updated on 6/26/2025 by MarketBeat.com Staff
From Our Partners